1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of giving 1-methyl-d-tryptophan
and docetaxel together in treating patients with metastatic solid tumors. Biological
therapies, such as 1-methyl-d-tryptophan, may stop the growth of tumor cells by stimulating
the immune system and by blocking some of the enzymes needed for cell growth. Drugs used in
chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing. Giving 1-methyl-d-tryptophan
with chemotherapy may kill more tumor cells.